By service
Building HCP trust through content and customer experience
Every HCP touchpoint you create is content. But building trust with HCPs takes more than just balancing promotional and educational content. You need to understand their needs, expectations and experience.
7 common mistakes in hybrid pharma sales and omnichannel engagement (and how to fix them)
Hybrid selling is a core part of pharma sales strategies. But staying ahead means more than a few digital assets and a virtual event – it requires aligning teams, tools and tactics whilst avoiding these common mistakes.
Securing formulary – optimising existing therapies – case study
Volume prescription sales of product increased from 16.4% to 32.4% market share in first three months of project.
Evolving CSO: meeting brand needs through diverse engagement models
Uniphar Commercial’s Client Solutions Director, Mark Ward, explores how the evolving go-to-market model needs a blended mix of digital and in-person activity that can be dialled up, or down, according to market dynamics.
Streamline outsourced team management with digital platforms
The pharma industry demands agility and first-class sales performance to stay competitive. Discover the digital platforms that will deliver results.
Activating a new EU market entrant through digital transformation – case study
The client was a new entrant into the EU market after having a large presence in eastern Asia and a growing presence in the US. They were 2-3 years away from launching their first product in the EU.
Power your people strategy with data-driven insights
Are you harnessing data to shape your people strategy? It’s essential for driving brand success. By leveraging insights, you can deploy your sales team with confidence knowing they’re in the right territories, with the right target customers to have impact.
Not all pharma CSOs are created equal
Additional sales support can drive your brands to market success. This is where contract sales organisations come into play. However, not all CSOs offer the same level of value and expertise. So, how do you make the right choice?
Increasing prescribing with our combined skills
A pharma company with multiple brands across a range of therapy areas needed an increase in prescribing.
Patient identification resource
The patient identification resource (PIR) was required to accelerate patient access to the client’s brand. It was designed to support identification of patients suitable for the brand, following a promotional call, where a healthcare organisation had made the decision to optimise patient care using the brand.
Primary care sales: bespoke build and deployment
A global pharma-leader was looking to maintain and grow sales for a product 13 years into its lifecycle.
The impact of EU pharmaceutical reform
Uniphar was delighted to welcome European industry leaders to Zurich to debate the proposed EU pharmaceutical legislation reform, and incoming HTA reform. The conversation was held against the backdrop of the EU elections, and discussions focused on the impact of both on the pharma industry globally.